
Ankeet Bhatt, MD, MBA, ScM, explains how prediction markets could threaten clinical trial integrity by undermining participant retention and trust.
Panelists discuss the prevalence of chronic kidney disease (CKD) in patients with type 2 diabetes and how CKD significantly impacts overall patient health.






